Androgen-responsive FOXP4 is a target for endometrial carcinoma

Abstract Although low estrogen is considered to suppress uterine endometrial carcinoma, the most cases occur in the postmenopausal stage. After menopause, the production of androgen level also declines. Therefore, to resolve the above enigma, we hypothesize that the postmenopausal decline of androge...

Full description

Bibliographic Details
Main Authors: Kayo Kayahashi, Mahadi Hasan, Anowara Khatun, Susumu Kohno, Jumpei Terakawa, Shin-ichi Horike, Natsumi Toyoda, Ayumi Matsuoka, Takashi Iizuka, Takeshi Obata, Masanori Ono, Yasunari Mizumoto, Chiaki Takahashi, Hiroshi Fujiwara, Takiko Daikoku
Format: Article
Language:English
Published: Nature Portfolio 2024-06-01
Series:Communications Biology
Online Access:https://doi.org/10.1038/s42003-024-06433-w